Story Details
What Crisis? Biopharma Rallies Strongly After COVID-19 Shock: New Report from Evaluate Vantage
https://theinscribermag.com -
“Pharma, Biotech and Medtech Half-Year Review 2020” analyses the market performance and deal landscape for the first half of 2020, focusing on the impact of COVID-19 LONDON & BOSTON & TOKYO–(BUSINESS WIRE)–#biopharma–Despite a $464 billion loss in market capitalisation in Q1 due to the ongoing COVID-19 pandemic, biopharma finished the first half of 2020 up, […]
The post What Crisis? Biopharma Rallies Strongly After COVID-19 Shock: New Report from Evaluate Vantage appeared first on INSCMagazine.
The post What Crisis? Biopharma Rallies Strongly After COVID-19 Shock: New Report from Evaluate Vantage appeared first on INSCMagazine.
Submit a Comment